Clarityn-D 12Hour Repetabs Adverse Reactions

During controlled clinical studies with the recommended dosage, the incidence of adverse effects associated with Clarityn-D 12Hour Repetabs was comparable to that of placebo, with the exception of insomnia and dry mouth, both of which were commonly reported. Other reported adverse reactions associated with both Clarityn-D 12Hour Repetabs and placebo included severe headache and somnolence; visual disturbance, nausea, vomiting, seizure.
Rare adverse reactions in decreasing order of frequency included nervousness, dizziness, fatigue, nausea, abdominal distress, anorexia, thirst, tachycardia, pharyngitis, rhinitis, acne, pruritus, rash, urticaria, arthralgia, confusion, dysphonia, hyperkinesia, hypoesthesia, decreased libido, paraesthesia, tremor, vertigo, flushing, postural hypotension, increased sweating, weight and appetite; eye disorders, earache, tinnitus, taste abnormality, agitation, apathy, depression, euphoria, paroneiria, change in bowel habits, dyspepsia, eructation, hemorrhoids, tongue discolouration and disorder; vomiting, transient abnormal hepatic function, dehydration, hypertension, palpitation, migraine, bronchospasm, coughing, dyspnea, epistaxis, sneezing, nasal congestion and irritation, dysuria, micturition disorder, nocturia, polyuria, urinary retention, asthenia, back pain, leg cramps, malaise and rigors.
During the marketing of loratadine, alopecia, anaphylaxis and abnormal hepatic functions have been reported rarely.